Эндотоксинемия в патогенезе отека легких при инфаркте миокарда

Белопухов Валерий Матвеевич, Якупов Искандер Файрузович, Корчагина Ксения Валерьевна et al. · Medical Almanac · 2013

Nowadays the therapy of acute heart failure (AHF) has achieved considerable clinical results. However, the treatment of cardiogenic pulmonary edema (CPE), as the most severe complication of AHF, still has some unsolved problems, which worsen the course of the disease and increase the lethality rate among the patients with myocardial infarction. There are the cases in practice when severe CPE, followed by invasive APV or after cardiopulmonary reanimation, leads to the development of multiple-organ-failure syndrome, which makes worse the prognosis for patients with myocardial infarction. The article gives the basic pathogenic mechanisms which lead to the development of multiple-organ-failure syndrome. One of the main factors, triggering the cascade of the reactions which lead to multiple-organ-failure syndrome, are endotoxins of gram-negative bacteria, residents of intestinal microflora. The discovery of cell receptor of endotoxin TLR4 (Toll-like receptor 4) helped the scientists in the understanding of the correlation of endotoxin with cells and carrying of its toxic signal. As many scientists consider, the complex of the effects of endotoxin on the factors of clotting lead to the activation of blood coagulation system and the development of severe generalized reaction of DIC and to the advance of multiple-organ-failure syndrome (MOFS). There is still no information that it is important to fight with endotoxemia in case of cardiogenic pulmonary edema. At a present moment the prediction and diagnosing of the patients with prolonged left ventricular failure and high risk of multiple-organ-failure syndrome is necessary. The retrieval for early markers of MOFS can be productive for every doctor of intensive care unit, because it can help to correct the therapy before the development of the terminal stage of multiple-organ-failure. It is possible that the revealing of endotoxins in blood can help to diagnose the early stages of MOFS of patients with CPE.

Cited by 0 works.

Authors